FDA Mandates Changes to iPLEDGE Program for Isotretinoin FDA Mandates Changes to iPLEDGE Program for Isotretinoin

Isotretinoin manufacturers have 6 months to make five changes to existing iPLEDGE Risk Evaluation and Mitigation Strategy (REMS) requirements for isotretinoin.MDedge News

Source: Medscape Nurses Headlines - December 6, 2023 Category: Nursing Tags: Dermatology Source Type: news